Identifying and Developing
Breakthrough Medicines

Bexion Pharmaceuticals is committed to the discovery and clinical development of life-changing oncology treatments. We leverage over 100 years of life science leadership to accelerate our clinical development program and are driven by the promise of developing life-changing oncology therapies on our path to become a leading biotech/pharmaceutical company.

Bexion Pharmaceuticals
Corporate Video

Bexion Milestones

Making Significant Progress

Bexion Media

PRESS RELEASE

Bexion Pharmaceuticals Announces Database Lock in Phase 1 Trial of BXQ-350
December 10, 2020

FOR IMMEDIATE RELEASE Covington, KY, December 10, 2020 Bexion Pharmaceuticals, Inc., a clinical stage biotech company focused on the discovery and development of life-changing treatments by leveraging the lysosome’s roles in solid tumors and cell death with an initial focus on cancer, announced today the database lock for the Phase 1 study of BXQ-350 in adult patients […]